Abstract
There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Current Pharmaceutical Design
Title: Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Volume: 16 Issue: 24
Author(s): Cristian R. Munteanu, Enrique Fernandez-Blanco, Jose A. Seoane, Pilar Izquierdo-Novo, Jose Angel Rodriguez-Fernandez, Jose Maria Prieto-Gonzalez, Juan R. Rabunal and Alejandro Pazos
Affiliation:
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Abstract: There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Export Options
About this article
Cite this article as:
R. Munteanu Cristian, Fernandez-Blanco Enrique, A. Seoane Jose, Izquierdo-Novo Pilar, Angel Rodriguez-Fernandez Jose, Maria Prieto-Gonzalez Jose, R. Rabunal Juan and Pazos Alejandro, Drug Discovery and Design for Complex Diseases through QSAR Computational Methods, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389252
DOI https://dx.doi.org/10.2174/138161210792389252 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice
Current Vascular Pharmacology Management of Blood Pressure and Heart Rate in Patients with Acute Stroke
Current Pharmaceutical Design Can the Electrophysiological Action of Rosiglitazone Explain its Cardiac Side Effects?
Current Medicinal Chemistry Quantification of Shear Stress and Geometric Risk Factors in Carotid Atherosclerosis: Review and Clinical Evidence
Recent Patents on Medical Imaging Small-Molecules Targeting Kinases Involved in Pulmonary Hypertension: a Patent Review (2010-2015)
Current Medicinal Chemistry Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Alzheimer Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies
CNS & Neurological Disorders - Drug Targets Biosynthesis and Biological Activities of In Vitro Derived Solasodine Glycoalkaloids from <i>Solanum laciniatum</i>
The Natural Products Journal Anti-inflammatory and Immune Therapy for Alzheimers Disease: Current Status and Future Directions
Current Neuropharmacology Genetics and Heart Failure: A Concise Guide for the Clinician
Current Cardiology Reviews Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design Label-Free Cell Phenotypic Drug Discovery
Combinatorial Chemistry & High Throughput Screening Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Patent Foramen Ovale in Cerebral Infarction
Current Cardiology Reviews Pharmacological Drug Delivery Strategies for Improved Therapeutic Effects: Recent Advances
Current Pharmaceutical Design Subject Index To Volume 4
Current Vascular Pharmacology Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Novel Therapeutic Targets for Diabetic Nephropathy
Endocrine, Metabolic & Immune Disorders - Drug Targets Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design